Northwest Biotherapeutics Inc
NWBO· OTC
NWBONorthwest Biotherapeutics Inc
Filed Nov 14, 2012 · 10-Q · 45 days after period end · 0001144204-12-062199
| Metric | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|
| Revenue | $120.00K | $10.00K | $10.00K |
| Net Income | -$16.50M | $482.00K | -$5.38M |
| EPS Diluted | -$1.50 | $0.06 | -$0.08 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Northwest Biotherapeutics Inc · CIK 1072379 · Engraved from SEC EDGAR
ended Sep 30, 2012 · filed Nov 14, 2012 · 45 d after period end
